Patent Strategy Sample Clauses
The Patent Strategy clause outlines how parties will manage, protect, and exploit patent rights arising from their collaboration or agreement. Typically, it specifies which party is responsible for filing patent applications, how costs and ownership of resulting patents are allocated, and the process for making decisions about patent prosecution or enforcement. This clause ensures that both parties have a clear understanding of their roles and rights regarding intellectual property, thereby preventing disputes and facilitating effective commercialization of inventions.
POPULAR SAMPLE Copied 2 times
Patent Strategy. The Project Managers shall be responsible for managing and reviewing the patent strategy for inventions made in the course of the Development Program and shall meet monthly to review invention disclosures, identify patentable inventions, determine inventorship, and determine whether patents should be sought for such inventions in accordance with Article 9 (Intellectual Property Rights and Infringement).
Patent Strategy. Notwithstanding MacroGenics’ right to file, prosecute and maintain the MacroGenics Multi-Product Patents:
(1) the Parties will, and will cause their Affiliates to, cooperate and implement reasonable patent filing and prosecution strategies (including filing divisionals, continuations or otherwise) so that, to the extent reasonably feasible, the MacroGenics Product-Specific Patents, MacroGenics Platform Patents and MacroGenics Multi-Product Patents are pursued in mutually exclusive patent applications; (2) at Gilead’s request and expense, MacroGenics will file any new MacroGenics Product-Specific Patents in a separate patent application from the existing MacroGenics Platform Patents and MacroGenics Multi-Product Patents, in each case to the extent reasonably feasible and in a manner that does not materially prejudice the prosecution of other MacroGenics Licensed Patents; and (3) for any MacroGenics Licensed Patents for which MacroGenics is responsible for filing, to the extent legally permitted by the applicable patent authority, MacroGenics will segregate claims to CD123 Products from products directed to other targets into separate Patents.
Patent Strategy. The Advisory Committee shall be responsible for managing and reviewing the patent strategy in the Territory for use of the Drug Delivery System in the Field (the "Patent Strategy"). The Patent Strategy shall include, but not be limited to, deciding on the question of inventorship of any inventions arising under this Agreement, agreeing on the desired scope of patent protection to be secured by Genetronics, agreeing on the desired scope of patent protection to be secured for Joint Inventions, and recording and advising the parties on all patents secured in furtherance of hereunder. Genetronics shall develop and propose to the Advisory Committee annual budgets for the Patent Strategy for its review and consent.
Patent Strategy. Subject to the provisions of this Article 14, the parties will cooperate in the development and execution of a patent strategy that maximizes patent protection of Products throughout the Territory and minimizes patent expenses. With respect to Joint Patents in particular, Geron and P&U shall decide by mutual written agreement on a case-by-case basis the party with primary responsibility for Joint Patent filings, prosecution, and maintenance. Each party shall assure that each of its employees, consultants and other contractors who perform the Research shall be lawfully obligated to assign or license all inventions conceived or reduced to practice during the course of performing such work to such party.
Patent Strategy. Notwithstanding anything to the contrary set forth herein, strategic decisions relating to the prosecution (including decisions relating to reexamination or reissue of issued patents) of DAP Patents, Replidyne Patents or Forest Patents in the Territory and material components of the implementation of such decisions shall require the consensus of Forest, Replidyne and DAP (as to DAP, to the extent provided by the DAP Agreement).
Patent Strategy. With respect to all Patent preparation, filing, prosecution and maintenance, defense, and enforcement activities described in this Article 9, the Parties will discuss, confer and cooperate in good faith with respect to the overall Patent strategy with respect to the Licensed Territory and Retained Territory. Each Party, acting reasonably and in good faith, will consider the comments of the other Party in connection with the Patent strategy.